Anti-FGFR-3 Autoantibodies ELISA

$1,765.00

The Anti-FGFR-3 Autoantibodies ELISA is designed for the determination of Antibodies (IgG) against the FGFR3 in human serum. The Anti-FGFR-3 Autoantibodies ELISA is intended for research use only and not for use in diagnostic or clinical procedures.

Anti-FGFR-3 Autoantibodies ELISA

The Anti-FGFR-3 Autoantibodies ELISA is For Research Use Only

Size: 1×96 wells
Sensitivity: 0.8 Units/ml
Dynamic Range: 1.25 U/ml and 40 U/ml
Incubation Time: 3 hours 20 minutes
Sample Type: Serum
Sample Size: 100 µL
Alternative Names: Fibroblast growth factor receptor 3, CD333
Controls Included


Assay Principle

The anti-FGFR3-antibody-EIA is an antibody screening test. The FGFR3 protein has been pre-coated onto a microtiter plate. During the first incubation the anti-FGFR3-antibodies of the samples are immobilised on the plate. The autoantibodies are detected with a POD labeled antihuman IgG antibody. In the following enzymatic substrate reaction the intensity of the colour correlates with the concentration and/ or avidity of anti-FGFR3-antibodies.


Related Products

Anti-ETB IgG Antibody ELISA
Anti-Aprotinin IgG Antibodies ELISA
Anti-Beta1-Adrenergic Receptor Antibody IgG ELISA

Additional Information

Assay Background


Fibroblast growth factor receptor 3 (CD333) is a protein that in humans is encoded by the FGFR3 gene. Fibroblast growth factor receptor 3 interact with FGF8 and FGF9. FGFR3 inhibitors are in early clinical trials as a cancer treatment for urothelial carcinoma. FGFR3 antibodies have been reported in sensory neuropathy.

Documents

Product Manual